These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12996501)

  • 21. Inhibition of ulcer formation in the Shay rat and reduction of gastric acidity in dogs by antrenyl (oxyphenonium) (BA5473) diethyl(2-hydroxyethyl)methylammonium bromide alpha-phenyl-cyclohexaneglycolate, an anticholinergic agent.
    BARRETT WE; RUTLEDGE R; PLUMMER AJ; YONKMAN FF
    J Pharmacol Exp Ther; 1953 Jul; 108(3):305-16. PubMed ID: 13070149
    [No Abstract]   [Full Text] [Related]  

  • 22. [The therapy of gastroduodenal ulcer and gastroduodenitis with the association of an anticholinergic drug, a tranquilizing agent and an antacid].
    FERRERAS BLANCO E
    Med Clin (Barc); 1963 Feb; 40():114-8. PubMed ID: 13944899
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effective long-acting anticholinergic therapy].
    MEEROFF M
    Dia Med; 1961 Oct; 33():2446-8. PubMed ID: 14472082
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on a new anticholinergic drug, marplan.
    BACHRACH WH
    J Lab Clin Med; 1956 Oct; 48(4):603-6. PubMed ID: 13367598
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of a new anticholinergic agent in digestive pathology and especially in gastroduodenal ulcers].
    MONGES H; LEGRE M; GAUTHIER AP
    Mars Med; 1962; 99():609-15. PubMed ID: 14475378
    [No Abstract]   [Full Text] [Related]  

  • 26. Hexocyclium methosulfate, a new anticholinergic drug in conventional and long-acting forms: its effects on gastric secretion; the effects of hexocyclium (a) on the pH of gastric secretion as studied by 48-hour gastric analysis, (b) on volume and acidity of nocturnal secretion, and (c) in the management of peptic ulcer.
    KASICH AM
    Schweiz Z Pathol Bakteriol; 1958; 21(2):354-62. PubMed ID: 13555797
    [No Abstract]   [Full Text] [Related]  

  • 27. [Our experience with an anticholinergic agent with prolonged action: isopropamide iodide].
    MEEROFF M
    Sem Med; 1961 Apr; 118():711-7. PubMed ID: 13768938
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of anticholinergic drugs on the mucus content of gastric juice.
    PIPER DW; STIEL MC; FENTON B
    Gut; 1962 Jun; 3(2):177-80. PubMed ID: 14486840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prantal in long-term anticholinergic therapy.
    RIESE JA
    Am J Dig Dis; 1956 Jan; 1(1):31-4. PubMed ID: 13282861
    [No Abstract]   [Full Text] [Related]  

  • 30. [TRANQUILIZING AGENTS IN THE TREATMENT OF GASTRODUODENAL ULCER. (RESULTS OBTAINED WITH THE ASSOCIATION OF AN ANSIOLYTIC: CHLORODIAZEPOXIDE AND AN ANTICHOLINERGIC: CLIDINIUM BROMIDE].
    GALANNAVARRO JL
    Rev Clin Esp; 1964 Mar; 92():342-51. PubMed ID: 14142206
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic action of the new synthetic anticholinergic agent, benzylonium bromide, in diseases of the digestive tract].
    SUROS J; BORDAS-FELIU JM; GOBERN J; SUROS-BATLLO J
    Med Clin (Barc); 1963 Mar; 40():181-5. PubMed ID: 13979343
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new anticholinergic agent: Ambutonium, in the treatment of ulcerous disease].
    POIRIER JP
    Sem Hop Ther Paris; 1961 Dec; 37():945-7. PubMed ID: 14487446
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new vagolytic and anticholinergic compound: banthine, its utilization in digestive pathology].
    BERTRAND J
    Concours Med; 1952 May; 74(19):1781-5. PubMed ID: 12979458
    [No Abstract]   [Full Text] [Related]  

  • 34. SIEGEL L, GOLDBERG RI: A clinical evaluation of a new anticholinergic compound, glycopyrrolate.
    LAMPHIER TA
    Am J Gastroenterol; 1962 May; 37():551-5. PubMed ID: 14461852
    [No Abstract]   [Full Text] [Related]  

  • 35. [ULCER TREATMENT WITH ANTICHOLINERGICS].
    DOTEVALL G; SCHROEDER G; WALAN A
    Sven Lakartidn; 1964 Apr; 61():1458-64. PubMed ID: 14145139
    [No Abstract]   [Full Text] [Related]  

  • 36. [COMPARATIVE EVALUATION OF THE EFFECT OF CHOLINOLYTIC DRUGS (HEXONIUM, FUBROMEGAN AND QUATALERON) ON THE DEVELOPMENT OF EXPERIMENTAL ULCER].
    LIPOVSKII SM
    Farmakol Toksikol; 1963; 26():684-7. PubMed ID: 14176177
    [No Abstract]   [Full Text] [Related]  

  • 37. [Early therapeutic results of a new substance with anticholinergic action: iodide of 1-(N-diethylmethylaminoethyl)-5-ethyl-5-phenylbarbituric acid (C.S. 11 or defenal)].
    MANNELLI R; NESI G
    Minerva Med; 1953 May; 44(39):1282-4. PubMed ID: 13072041
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of gastroduodenal ulcer with anticholinergics].
    VAGUE J; BERNARD A; FAVIER G
    Union Med Can; 1955 Nov; 84(11):1245-53. PubMed ID: 13282005
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current value of anticholinergics in the treatment of peptic ulcer and certain disorders of the digestive system].
    STAPLER NM
    Arch Mal Appar Dig Mal Nutr; 1956 Nov; 45(11):377-84. PubMed ID: 13382401
    [No Abstract]   [Full Text] [Related]  

  • 40. LONG-TERM ANTICHOLINERGIC THERAPY FOR PREVENTION OF RECURRENCES IN DUODENAL ULCER.
    SUN DC
    Am J Dig Dis; 1964 Oct; 9():706-16. PubMed ID: 14215823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.